Wolthers, Ole D <br/><br/>
Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate.  [electronic resource] 

 -  Recent patents on inflammation & allergy drug discovery  2015 
 - 144-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-213X 
<br/><br/><label>Standard No.: </label>10.2174/1872213x10666151119144907  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Administration, Oral<br/>Adrenal Cortex Hormones--administration & dosage<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Age Factors<br/>Androstadienes--administration & dosage<br/>Animals<br/>Anti-Asthmatic Agents--administration & dosage<br/>Asthma--drug therapy<br/>Benzyl Alcohols--administration & dosage<br/>Biological Availability<br/>Bronchoconstriction--drug effects<br/>Bronchodilator Agents--administration & dosage<br/>Chlorobenzenes--administration & dosage<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Drug and Narcotic Control<br/>Humans<br/>Lung--drug effects<br/>Patents as Topic<br/>Risk Factors<br/>Treatment Outcome